Haemonetics (HAE) Misses Q2 EPS by 1c, Lowers FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Haemonetics 2nd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website
November 9, 2021 6:00 AM ESTBOSTON, Nov. 9, 2021 /PRNewswire/ --Â Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal 2022, which ended October 2, 2021, are available on its Investor Relations website.
... More
